70 likes | 223 Views
ESOF 2010 EMCDDA ScC Session. Marina Davoli, Roland Simon, Margareta Nilson. State of development. Luigi Civalleri - ESOF2010 - Scientific Programme Coordinator Via Po 18, 10123 Torino (Italy)
E N D
ESOF 2010EMCDDA ScC Session Marina Davoli, Roland Simon, Margareta Nilson
State of development Luigi Civalleri - ESOF2010 - Scientific Programme Coordinator Via Po 18, 10123 Torino (Italy) • “on behalf of ESOF2010 Programme Committee and organizing team, I congratulate all successful proponents. Welcome on board!” • 218 proposals from 26 countries received/ 97 proposals were accepted Questions to be answered soon: • 1. Speakers confirmed? Is the affiliation you provided correct? • 2. Moderator chosen? • 3. Date fixed? • 4. Do you confirm that your session will be completely self-financed?
ESOF2010 Torino 3. – 7. July 110 ordinary sessions, 4 Plenary Sessions and 18 Keynote Talks 5 Nobel Prize winners. Speakers with scientific pre-eminence and communication skills, cultural and gender diversity Themes • Sustainable living and moving • Evolution, development and adaptation of organisms • Moving into and up from our quantum world • Responding to global needs • Frontiers in energy research • Science, knowledge and belief • Memory and learning in organisms, social and artificial systems • Languages, cultures and variability • Integrating science with health care • Policy – what follows?
Some facts on ESOF2008 • Number of total participants: 4115 • Number of accredited media: 511 • Number of speakers: 452 • Session’s attendance: • - Plenary sessions: an average of 312 • - Keynote and parallel sessions: an average of 104 • Total number of Outreach participants: 10.000
The EMCDDA ScC Session: Synposis • experiences and possibilities to improve implementation of findings • describes how research has informed clinical practice and what problems this process can face. • Clinical research on pharmacological and psychosocial treatment has changed the understanding and treatment of addictions, whereas behavioural treatment has partly developed through advances in qualitative research. Compared to first proposal: cut down by 50%, concentrated on treatment
The EMCDDA ScC Session: Structure Research informing clinical practice – what works, and what does not Where transfer works/worked for pharmacological treatment John Strang 10’ Where transfer works/worked for psychosocial/behavioural treatment Michael Farrell 10’ What limits and hinders transfer Jurgen Rehm 15’ Part II: Research informing practice – ways to narrow the gap From research synthesis to clinical guidelines Marina Davoli 10’ Are guidelines of any use to clinicians? PierPaolo Pani 10’ Discussion with the panel: Ways to narrow the gap 20’ Overall duration: 75 Minutes
Next steps • Finalize list of speakers • Agree on outline of presentations • Guarantee funding and organise trips We will support Marina and Michael doing this